Researchers at VCU Massey Comprehensive Cancer Center are leading an international study that advances the understanding of ...
FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission -- 30-patient pivotal study initiated, evaluating seizure reduction and ...
BioCardia, Inc. (NASDAQ:BCDA) Q4 2025 Earnings Call Transcript March 24, 2026 BioCardia, Inc. beats earnings expectations.
Japan’s move to conditionally approve two induced pluripotent stem cell derived therapies marks a significant development for ...
The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for ...
Researchers identify the hippocampus and microglia as the "tipping point" that determines if chronic pain leads to depression ...
Achieve optimal heating with Cubic's intelligent combustion control for condensing boilers, featuring advanced sensors for ...
Q4 2025 Earnings Call March 24, 2026 4:30 PM EDTCompany ParticipantsMiranda Benvenuti - Investor Relations ExecutivePeter Altman ...
New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.
SUZHOU, China and MÖLNDAL, Sweden, March 20, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. ('Ribo' or 'the Company ...
Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results